← Eichor
Study identifier: NCT05512754 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

Condition: Elevated Serum PSA  ·  Sponsor: University of Chicago

PhasePhase 4
Planned participants200
Who can joinMale, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA.

This description comes directly from the study's public registry record.

Talk to the study team

Scott Eggener, MD  ·  773-834-5087  ·  seggener@bsd.uchicago.edu

Leila Yazdanbakhsh, MSCI  ·  7738345087  ·  leila.yazdanbakhsh@bsd.uchicago.edu

Always discuss trial participation with your own doctor first.

Locations (3)

University of ChicagoChicago, Illinois, United StatesRecruiting
Albany Medical CollegeAlbany, New York, United StatesRecruiting
The Pennsylvania State University at The Milton S. Hershey Medical CenterHershey, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05512754